Latvia Analgesic Medicine Sales is set to reach $13.42 Million by 2027 from $11.9 Million, will rise 4.8% per year. Since 2017, the market grew 0.6% year on year attaining $6,600 Million. Spain, Canada and Italy respectively were numbers 2, 3 and 4 in this ranking.
How does Latvia perform in Analgesic?
Forecast: Analgesic Medicine Sales in Latvia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Use in Latvia
- Units (Defined Daily Dosage) Per Thousand Persons Per Day
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Analgesic Medicine Sales in Latvia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Analgesic Medicine Use in Latvia
- Units (Defined Daily Dosage) Per Thousand Persons Per Day
- 2024 to 2028
- ReportLinker Research